News

Social media and personal calls patch rough relations.

Focus on exchanges gives plans an opening to repair their image among consumers.

Fear and dosing schedules are barriers

Tools help patients and physicians

Reinvent your market approach for long-term survival

Differentiate your brand as B2B becomes B2C

Discussion leaves a sense of uncertainty as to how coverage rules will play out

Invest in efficiency and consider big data

There are 20 states choosing not to expand their Medicaid programs under the ACA.

Four criteria

New cost pressures cloud the financial outlook

Will ACA exchanges earn 90% satisfaction ratings someday?

Florida Blue creates single-specialty ACOs

Few feel prepared for March deadline

Long-term intervention encompasses entire lifetime

Capitalize on industry changes in 2014

FDA has rejected alemtuzumab (Lemtrada, Genzyme, a Sanofi company) for the treatment of relapsing forms of multiple sclerosis.

NEJM researchers find the reasons behind the slowdown

Consumers have another 24 hours to shop and sign up

The newly enrolled individuals to the healthcare exchanges will be faced with higher out-of-pocket costs for their medications than those who receive insurance through their employers, according to an analysis by Avalere Health of more than 600 health plans in the exchanges.

Insurers face yet another about-face to accommodate consumers

Amneal Pharmaceuticals will start shipping its branded Esomeprazole Strontium 49.3 mg delayed-release capsules on December 18 to three major U.S. wholesalers. Its capsules contain the same active ingredient, esomeprazole, in a different salt form as found in Nexium (esomeprazole magnesium).

US life expectancy for people with cancer hit another all-time high, rising over 50 million life-years (LYS) after diagnosis, according to statistics collected through the Value of Medical Innovation initiative, led by the Center for Medicine in the Public Interest (CMPI).

Manufacturers of antibacterial hand soap and body wash will be required to show that their products are more effective than plain soap and water in preventing illness and the spread of infection, under a FDA-proposed rule.

Cloud, mobile, healthcare analytics and technology create new possibilities for better medical intelligence, benefits design and care.

Individuals diagnosed with rheumatoid arthritis (RA) more recently experienced decreased disability and psychological problems than those treated 20 years ago. While treatment strategies have helped, researchers attribute the positive effects to greater physical activity and encouragement of a worthwhile life by healthcare professionals.

The data is not necessarily perfect

Chronically ill patients in last years of life account for 32% of total Medicare spending.